A big win for patients and the first building block in what will be an improving toolbox for reducing death and disease from covid19. FDA's authorization allows for 5 day use in patients who aren't intubated, which will extend Gilead's supply of the drug.https://www.nbcnews.com/health/health-news/fda-grants-remdesivir-emergency-use-authorization-covid-19-n1197576 …
Replying to @ScottGottliebMD
What a big win for patients: the FDA bureaucracy is refining one of its hurdles. Let's hope that none of these patients will need it for 6 days, or gets intubation delayed so they can stay on the drug for a bit longer.
2:44 PM - 1 May 2020
0 replies
0 retweets
2 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.